SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·05/05/2025 21:05:47
Listen to the news
Gainers
- Rafael Holdings (NYSE:RFL) shares increased by 21.7% to $1.74 during Monday's after-market session. The market value of their outstanding shares is at $63.8 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares rose 17.73% to $1.66. The market value of their outstanding shares is at $22.8 million.
- SI-BONE (NASDAQ:SIBN) shares moved upwards by 14.45% to $16.31. The market value of their outstanding shares is at $693.6 million. As per the news, the Q1 earnings report came out today.
- Neurocrine Biosciences (NASDAQ:NBIX) shares rose 11.79% to $122.7. The market value of their outstanding shares is at $12.2 billion. The company's, Q1 earnings came out today.
- Oragenics (AMEX:OGEN) stock increased by 11.76% to $0.19. The market value of their outstanding shares is at $4.0 million.
- GlucoTrack (NASDAQ:GCTK) stock increased by 11.27% to $0.21. The market value of their outstanding shares is at $5.2 million.
Losers
- NuCana (NASDAQ:NCNA) shares decreased by 22.2% to $0.86 during Monday's after-market session. The company's market cap stands at $5.1 million.
- Tactile Systems Tech (NASDAQ:TCMD) stock declined by 15.0% to $11.85. The company's market cap stands at $280.4 million. As per the press release, Q1 earnings came out today.
- Citius Oncology (NASDAQ:CTOR) stock fell 9.24% to $0.85. The market value of their outstanding shares is at $60.7 million.
- HealthStream (NASDAQ:HSTM) stock decreased by 8.13% to $30.54. The market value of their outstanding shares is at $932.2 million. As per the news, the Q1 earnings report came out today.
- Senti Biosciences (NASDAQ:SNTI) stock fell 8.12% to $3.01. The market value of their outstanding shares is at $78.3 million.
- Corcept Therapeutics (NASDAQ:CORT) stock declined by 8.05% to $67.99. The company's market cap stands at $7.2 billion. The company's, Q1 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.